Key result
Thromboxane A2 analogue U-46619 potentiates submaximal Ca2+-activated force in umbilical artery smooth muscle via G proteins.
Why the study?
Does the thromboxane A2 analogue U-46619 potentiate calcium-activated force in permeabilized human umbilical artery smooth muscle?
Does the thromboxane A2 analogue U-46619 potentiate calcium-activated force in permeabilized human umbilical artery smooth muscle?
The thromboxane A2 analogue U-46619 potentiates calcium sensitivity of tension production in human umbilical artery smooth muscle via a G protein-mediated mechanism.
Answers are grounded in this paper and cite their sources.
Does not yet inform clinical management of umbilical tone; leaves open G protein pathways as targets for vascular research.
It has previously been shown that human umbilical artery (HUA) smooth muscle produces thromboxane A2 in response to increasing oxygen levels and that this thromboxane promotes contraction. To investigate the intracellular action of thromboxane A2, strips of HUA longitudinal smooth muscle were permeabilized using alpha-toxin from the bacterium Staphylococcus aureus. This treatment rendered the surface membrane permeable to low-molecular-weight substances but left functional thromboxane A2 receptors. Tension measurements were used to investigate the effect of the stable thromboxane A2 analogue, U-46619, on the Ca2+ sensitivity of smooth muscle contractile proteins. U-46619 (1 nM to 1 microM) potentiated submaximal Ca(2+)-activated force (generated by [Ca2+], 50 nM to 3 microM) but not maximal Ca(2+)-activated force (generated by [Ca2+], 10-100 microM). The specific thromboxane A2 receptor antagonist, GR-32191B (1 microM), inhibited the action of U-46619 (0.1 microM). The potentiation of submaximal Ca(2+)-activated force produced by the muscle in response to U-46619 (0.1 microM) was antagonized by guanosine 5'-O-(2-thiodiphosphate) (1 mM), the nonhydrolyzable analogue of GDP, and mimicked by guanosine 5'-O-(3-thiotriphosphate) (100 microM), the nonhydrolyzable analogue of GTP. These results suggest that U-46619 acts via the previously identified thromboxane A2 receptor to promote Ca2+ sensitivity of tension production in HUA smooth muscle. Furthermore, this effect appears to be mediated via a G protein.
No takes yet. Share an insight, caveat, or question.
Crichton et al. (1993) studied this question. U-46619 was evaluated on Ca2+ sensitivity of smooth muscle contractile proteins (submaximal Ca2+-activated force). The thromboxane A2 analogue U-46619 potentiated submaximal Ca2+-activated force in human umbilical artery smooth muscle, an effect mediated via a G protein.
Synapse has enriched 10 related papers. Consider them for comparative context: